Carlos P. Paya has shown strong personal investment in Vaxcyte, as highlighted by his recent insider trading activity. The financial data indicates that from June 2022 to January 2024, he has steadily increased his investment, peaking in November 2023 with...
Carlos P. Paya has shown strong personal investment in Vaxcyte, as highlighted by his recent insider trading activity. The financial data indicates that from June 2022 to January 2024, he has steadily increased his investment, peaking in November 2023 with shares valued around $1.81 million. His ongoing commitment to the company's success reflects how much skin he has in the game. As of 2023, his financial interests have been significantly tied to the company’s performance, and watching the evolving value of his holdings gives insight into his confidence in Vaxcyte's strategic direction.